| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/05/2002 | US20020122817 Solid instant-release forms of administration and process for producing the same |
| 09/05/2002 | US20020122815 Compositions and methods of carbohydrate dosing |
| 09/05/2002 | US20020122802 Diagnosis and treatment of malignant neoplasms |
| 09/05/2002 | US20020122800 Orally applying a mixture of a steroid and an inhibitor of TNF-alpha to treat aphthous |
| 09/05/2002 | US20020122799 Administering soluble receptor for advanced glycation endproduct (RAGE) in an amount effective to inhibit binding of advanced glycation endproducts to RAGE |
| 09/05/2002 | US20020122795 Compositions containing gangliosides for use in the treatment of skin disorders |
| 09/05/2002 | US20020122793 Heparinase III and uses thereof |
| 09/05/2002 | US20020122791 Antigenic CK-18 compounds for therapy and diagnosis and methods for using same |
| 09/05/2002 | US20020122784 N-long chain acyl-asparagine or glutamine; effects suitable for sensitive skin, dry skin, roughening skin or skin with atopic dermatitis |
| 09/05/2002 | US20020122774 Method for dispensing S-Adenosyl-methionine in a micro fine powdered form by inhalation |
| 09/05/2002 | US20020122773 Each optionally in the form of the enantiomers, mixtures of the enantiomers or in the form of the racemates; optionally hydrates or solvates |
| 09/05/2002 | US20020121919 Low voltage rail-to-rail CMOS output stage |
| 09/05/2002 | DE10207958A1 Solid formulation containing lipoic acid in molecularly dispersed form, useful e.g. as antiinflammatory, or in cosmetics or feed supplements, is storage stable |
| 09/05/2002 | DE10137459A1 Agent, useful for the treatment of diabetes mellitus, comprises a combination of cellulose and an alpha-glucosidase inhibitor |
| 09/05/2002 | DE10111163A1 Neue Siderophor-Antibiotikakonjugate mit 4- oder 6-zähnigen Eisenchelatoren auf der Basis von Aminosäuren oder Peptiden, Verfahren zu ihrer Herstellung und Ihre Anwendung New siderophore Antibiotikakonjugate with 4- or 6-dentate iron chelators on the basis of amino acids or peptides, process for their preparation and their use |
| 09/05/2002 | DE10110325A1 Phenylderivate 2 Phenyl derivatives 2 |
| 09/05/2002 | DE10110124A1 Composition for treating diabetes mellitus, especially of type II, comprising vegetable dietary fiber or cellulose and alpha-glucosidase inhibitor |
| 09/05/2002 | DE10109959A1 Treating or preventing bovine spongiform encephalopathy or related diseases, by administration of thiocyanate ions, preferably as nutritional supplement or feed additive |
| 09/05/2002 | DE10109898A1 Lipide mit veränderlicher Ladung Lipids with variable charge |
| 09/05/2002 | DE10109867A1 Verwendung von Triazolverbindungen zur Prophylaxe und Therapie neurodegenerativer Erkrankungen, Hirntrauma und zerebraler Ischämie Use of triazole compounds for the prophylaxis and treatment of neurodegenerative diseases, brain trauma and cerebral ischemia |
| 09/05/2002 | DE10109866A1 Triazolverbindungen und deren Verwendung zur Prophylaxe und Therapie neurodegenerativer Erkrankungen, Hirntrauma und zerebraler Ischämie Triazole compounds and their use for the prophylaxis and therapy of neurodegenerative diseases, brain trauma and cerebral ischaemia |
| 09/05/2002 | DE10109861A1 Neuartige seitenkettenhalogenierte Aminodicarbonsäurederivate Novel side-chain halogenated Aminodicarbonsäurederivate |
| 09/05/2002 | DE10109859A1 Neuartige Aminodicarbonsäurederivate Novel Aminodicarbonsäurederivate |
| 09/05/2002 | DE10109858A1 Neuartige halogensubstituierte Aminodicarbonsäurederivate Novel halogen-substituted Aminodicarbonsäurederivate |
| 09/05/2002 | DE10109856A1 Use of N-phenyl arylamide for treating or preventing chronic or acute hepatitis B viral infections in humans or animals, including co-infections with hepatitis D virus |
| 09/05/2002 | DE10109763A1 Pharmazeutische Salze Pharmaceutical Salts |
| 09/05/2002 | DE10109708A1 Improving solubility and incorporation of phytosterol in foods, nutritional supplements or body care agents by using a concentrate containing an emulsifier such as a polysorbate |
| 09/05/2002 | DE10109280A1 Indolderivate mit inhibitorischer Wirkung auf Proteinkinasen Indole derivatives having an inhibitory effect on protein kinases |
| 09/05/2002 | DE10108752A1 Neue Substituierte Imidazotriazinone New Substituted imidazotriazinones |
| 09/05/2002 | DE10108470A1 Verfahren zur Herstellung optisch aktiver Dihydropyrone A process for preparing optically active dihydropyrones |
| 09/05/2002 | DE10107828A1 Use of buprenorphin for treating urinary incontinence and related conditions, at below analgesic levels, particularly delivered from skin patches |
| 09/05/2002 | DE10107663A1 Testosteronhaltiges transdermales therapeutisches System und Verfahren zu seiner Herstellung Testosterone-containing transdermal therapeutic system and process for its preparation |
| 09/05/2002 | DE10107659A1 Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin Mucoadhesive disintegratable pharmaceutical preparation for drug delivery in veterinary and human medicine |
| 09/05/2002 | DE10106852A1 Entzündungshemmende Verbindungen Anti-inflammatory compounds |
| 09/05/2002 | CA2374147A1 Anti-wrinkle composition containing a derivative of polyaminoacid, and use of the said composition to combat wrinkling of the skin |
| 09/04/2002 | EP1236800A2 Nucleic acids encoding interferon alpha 2, containing single nucleotide polymorphisms and methods of use thereof |
| 09/04/2002 | EP1236799A2 Human nucleic acid sequences derived from breast tumor tissue |
| 09/04/2002 | EP1236728A2 S-type 2-substituted hydroxy-2-indolinylbutyric ester compounds and process for preparation thereof |
| 09/04/2002 | EP1236724A1 NEUTRALIZING AGENT FOR TOXIN OF MICROORGANISM BELONGING TO THE GENUS i CLOSTRIDIUM /i |
| 09/04/2002 | EP1236723A1 Sulfamide derivatives useful as beta3 agonists and pharmaceutical uses thereof |
| 09/04/2002 | EP1236720A1 Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors |
| 09/04/2002 | EP1236719A1 Novel heterocyclic compounds and salts thereof and medicinal use of the same |
| 09/04/2002 | EP1236711A2 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood |
| 09/04/2002 | EP1236477A2 A formative agent of protein complex |
| 09/04/2002 | EP1236476A1 Medicinal compositions for oral use |
| 09/04/2002 | EP1236475A2 Combination therapy for osteoporosis consisting of an estrogen agonist/antagonist and a growth hormone secretagogue |
| 09/04/2002 | EP1236474A1 Negative regulation of epidermal growth factor receptor activity by Mig-6 |
| 09/04/2002 | EP1236473A2 Self-assembling polynucleotide delivery system |
| 09/04/2002 | EP1236471A2 Angiostatic steroids |
| 09/04/2002 | EP1236470A2 Angiostatic steroids |
| 09/04/2002 | EP1236469A2 Angiostatic steroids |
| 09/04/2002 | EP1236468A1 Sulfonylaminocarbonyl derivatives for the treatment of nuclear factor-kappa B mediated diseases and disorders |
| 09/04/2002 | EP1236467A1 Inhalatory compositions of formoterol |
| 09/04/2002 | EP1236462A1 Multi-lamella based emulsion for stabilizing dermatologically useful ingredients and external preparation containing the same |
| 09/04/2002 | EP1235936A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 09/04/2002 | EP1235934A2 Screening method for candidate drugs |
| 09/04/2002 | EP1235933A2 Mammalian toxicological response markers |
| 09/04/2002 | EP1235924A1 Antisense modulation of rank expression |
| 09/04/2002 | EP1235916A2 Isolated polynucleotides having a reduced or an increased content of epigenetic control motifs and uses thereof |
| 09/04/2002 | EP1235915A2 Transgenic mammals into which a period 1 promoter that confers rhythmical expression has been introduced |
| 09/04/2002 | EP1235907A1 6 human secreted proteins |
| 09/04/2002 | EP1235900A1 Microparticle-based transfection and activation of dendritic cells |
| 09/04/2002 | EP1235899A1 Treatment of human infertility |
| 09/04/2002 | EP1235860A2 G-protein coupled receptors |
| 09/04/2002 | EP1235851A2 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 09/04/2002 | EP1235850A1 Unsaturated 14,15-cyclopropane-androstanes, a method for their production and pharmaceutical compositions containing these compounds |
| 09/04/2002 | EP1235849A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 09/04/2002 | EP1235847A2 ISOLATION OF FIVE NOVEL GENES CODING FOR NEW Fc RECEPTORS-TYPE MELANOMA INVOLVED IN THE PATHOGENESIS OF LYMPHOMA/MELANOMA |
| 09/04/2002 | EP1235846A1 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 09/04/2002 | EP1235845A2 24 human secreted proteins |
| 09/04/2002 | EP1235844A1 28 human secreted proteins |
| 09/04/2002 | EP1235843A1 26 human secreted proteins |
| 09/04/2002 | EP1235838A1 23 human secreted proteins |
| 09/04/2002 | EP1235835A1 Chromium-histidine complexes as nutrient supplements |
| 09/04/2002 | EP1235834A1 (1r,cis)-4-(4-amino-7h-pyrr0l0[2,3- i(d)]pyrimidine-7-yl)-2-cyclopentene-1-methanol derivatives as antiviral |
| 09/04/2002 | EP1235833A1 Analogs of (1s, cis)-4-(2-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol as antiviral |
| 09/04/2002 | EP1235831A2 New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 09/04/2002 | EP1235830A2 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 09/04/2002 | EP1235829A2 Pyrazolo 1,5-d] 1,2,4]triazines for enhancing cognition |
| 09/04/2002 | EP1235827A2 Imidazo-pyridine derivatives as ligands for gaba receptors |
| 09/04/2002 | EP1235826A1 Quinuclidine acrylamides |
| 09/04/2002 | EP1235825A1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 09/04/2002 | EP1235824A1 Vitamin d analogues |
| 09/04/2002 | EP1235815A1 Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes |
| 09/04/2002 | EP1235814A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS |
| 09/04/2002 | EP1235812A2 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 09/04/2002 | EP1235810A1 Process of making substituted pyrazoles |
| 09/04/2002 | EP1235809A1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments |
| 09/04/2002 | EP1235808A2 Tricyclic analgesics |
| 09/04/2002 | EP1235807A1 B-amino acid-, aspartic acid- and diaminopropionic-based inhibitors of factor xa |
| 09/04/2002 | EP1235803A1 Urea compounds having muscarinic receptor antagonist activity |
| 09/04/2002 | EP1235802A1 Carbamate derivatives having muscarinic receptor antagonist activity |
| 09/04/2002 | EP1235801A2 Solid pharmaceutical preparation |
| 09/04/2002 | EP1235799A1 Polymorphic form of atorvastatin calcium |
| 09/04/2002 | EP1235798A1 1,4 substituted piperidinyl nmda/nr2b antagonists |
| 09/04/2002 | EP1235797A1 Aralkyl-1,2-diamines having calcimimetic activity and preparation mode |
| 09/04/2002 | EP1235793A2 Vla-4 integrin antagonists |
| 09/04/2002 | EP1235787A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 09/04/2002 | EP1235785A2 Novel compounds to treat diabetes and associated conditions |
| 09/04/2002 | EP1235777A2 Vitamin d analogues |